Evidence map›Paper›PMID 33238593›Full record

ArticleBiomolecules2020

A Synthetic CPP33-Conjugated

Seong-Lan Yu, Han Koo, Se-In Lee, JaeKu Kang, Young-Hyun Han, Young Il Yeom, Dong Chul Lee

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Seong-Lan YuPriority Research Center, Myunggok Medical Research Institute, College of Medicine, Konyang University, Daejeon 35365, Korea.
Han KooPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea.ORCID 0000-0003-1165-3173
Se-In LeePriority Research Center, Myunggok Medical Research Institute, College of Medicine, Konyang University, Daejeon 35365, Korea.
JaeKu KangPriority Research Center, Myunggok Medical Research Institute, College of Medicine, Konyang University, Daejeon 35365, Korea.ORCID 0000-0002-8660-7940
Young-Hyun HanPriority Research Center, Myunggok Medical Research Institute, College of Medicine, Konyang University, Daejeon 35365, Korea.
Young Il YeomPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea.
Dong Chul LeePersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea.
Konyang University · KRKorea Research Institute of Bioscience and Biotechnology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Homeobox A9 (

Indexed as

AnimalsAntigens, CDCadherinsCarcinoma, Non-Small-Cell LungCell Line, TumorCell MovementCell-Penetrating PeptidesDisease Models, AnimalDown-RegulationEpithelial-Mesenchymal TransitionHomeodomain ProteinsHumansLung NeoplasmsMice, Inbred BALB CMice, NudeNeoplasm InvasivenessAntigens, CDCadherinsCDH1 protein, humanCell-Penetrating Peptideshomeobox protein HOXA9Homeodomain ProteinsNF-kappa BSNAI2 protein, humanSnail Family Transcription Factorscell invasionCPP33-HADPHOXA9non-small cell lung cancerSNAI2

Identifiers

PMID33238593
PMCPMC7700116
OpenAlexW3110446529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.